Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jingjia Medical Technology is a Chinese medical biomaterials and medical aesthetics company focused on the development, manufacturing, and commercialization of medical-grade sodium hyaluronate products. The company markets hyaluronic acid-based products under the HAFILLER brand, including injectable dermal fillers and ophthalmic viscosurgical devices, and it also highlights applications in anti-adhesion and joint lubrication. Jingjia Medical positions itself as a long-established manufacturer with nearly three decades of sodium hyaluronate R&D and production experience. In addition to branded products, it offers OEM services and exports to multiple international markets. The company appears to operate primarily as a commercial-stage medical device and biomaterials manufacturer rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Jingjia Medical Technology.